skip to the main content area of this page

Please note: will be shut down in the course of 2021.

The eyeMoviePedia videos are moving successively to be found on PUBLISSO-Repository for Life Sciences (FRL) in the future.
To view the new eyeMoviePedia collection, please click here.

Implanting the Argus® II Retinal Prosthesis System in a patient with dry AMD

Hello, you either have JavaScript turned off or an old version of Adobe's Flash Player.
To view the content of this site you'll have to turn JavaScript on and have a current version of Adobe's Flash Player.

Get the latest Flash player.

Views: 4735

Download this video...
  • Download this video
Share or Bookmark this video...
  • Facebook
  • Google
  • MisterWong
  • TwitThis
  • Yahoo! MyWeb
  • Yahoo! Buzz

Implanting the Argus® II Retinal Prosthesis System in a patient with dry AMD

DOI: 10.3207/2715920703

The following is an edited movie of a previously live-streamed surgical video featuring renowned Consultant Ophthalmologist and Vitreoretinal surgeon Professor Paulo E. Stanga, MD, implanting the Argus® II Retinal Prosthesis System in a patient with dry Age Related Macular Degeneration (AMD). To date, June 2016, over 180 Argus® II devices have been implanted worldwide, and are used routinely in advanced Retinitis Pigmentosa patients. This video, recorded at Manchester Royal Eye Hospital, UK,  in April 2016, shows Prof. Stanga performing the procedure on a dry AMD patient as part of an investigational study of the Argus® II system in dry AMD ( #NCT02227498, being conducted under an approval from MHRA and the Ethics Committee at Manchester Royal Eye Hospital). The trial patients are the first in history to combine artificial vision provided by the Argus® II with their remaining natural peripheral sight. The surgery is commentated by Dr. Suber Huang, of University Hospitals Case Medical Center, Cleveland, Ohio and Francesco Merlini of Second Sight Medical Products Inc.



Author: Professor Paulo Stanga
Submitted: 27/06/2016
Published: 14/09/2016
Views: 4735

Comments (0)

Comments are closed.